Allurion Technologies (Allurion Technologies) Change In Receivables : $0.78 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Change In Receivables?

Allurion Technologies's change in receivables for the quarter that ended in Mar. 2024 was $1.67 Mil. It means Allurion Technologies's Accounts Receivable declined by $1.67 Mil from Dec. 2023 to Mar. 2024 .

Allurion Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was $-1.32 Mil. It means Allurion Technologies's Accounts Receivable increased by $1.32 Mil from Dec. 2022 to Dec. 2023 .

Allurion Technologies's Accounts Receivable for the quarter that ended in Mar. 2024 was $16.16 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Allurion Technologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 157.10.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Allurion Technologies's liquidation value for the three months ended in Mar. 2024 was $-81.53 Mil.

Allurion Technologies Change In Receivables Historical Data

The historical data trend for Allurion Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Change In Receivables Chart

Allurion Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Change In Receivables

-0.93

-22.82

-1.32

Allurion Technologies Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial					-0.43	1.36	-4.81	2.57	1.67

Allurion Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.78 Mil.

Allurion Technologies (NYSE:ALUR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Allurion Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	16.159	/	9.386	*	91
=	157.10

2. In Ben Graham's calculation of liquidation value, Allurion Technologies's accounts receivable are only considered to be worth 75% of book value:

Allurion Technologies's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	29.682	-	126.15	+	0.75 * 16.159	+	0.5 * 5.631
=	-81.53

Allurion Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Allurion Technologies (Allurion Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Huron Drive, Natick, MA, USA, 01760

Website

Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Executives

Omar Ishrak	director	710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin	director	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta	director, 10 percent owner	307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth	officer: Chief Financial Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin	director	C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson	director	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon	officer: Chief Commercial Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur	director, officer: Chief Executive Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani	officer: Chief Medical Officer	11 HURON DRIVE, SUITE 200, NATICK MA 01760